Anti-CDX2 Antibody

Produced by Antibodies.com, this unconjugated Mouse monoclonal IgG2b reagent recognises the CDX2 homeobox transcription factor, a nuclear differentiation marker central to intestinal epithelium biology and colorectal carcinoma research. It is supplied at 100 µl per vial and validated for Western blot, immunoprecipitation, and immunocytochemistry workflows. Demonstrated reactivity spans Human, Monkey, and Mouse samples, supporting comparative studies and patient-derived cell line work. Researchers deploy the antibody to characterise intestinal differentiation in colon adenocarcinoma models, monitor goblet-cell markers in engineered organoids, and distinguish primary from metastatic colorectal lesions in cytology preparations.